EUVIMEDEUVIMED entdecken
Crossref

Rapid Diagnostic Methods for Detecting Antimicrobial Resistance in Clinical Microbiology and Their Role in Guiding Antibiotic Treatment: A Narrative Review

Roheena Zafar, Taimoor Khan, Hafiz Yaseen Khan, Yaseen Naveed, Bilal Musa

Journal of Pharma and Biomedics · 04.11.2026 · 4 (4) · 545-552

DOI: 10.56810/jpbm.004.04.0318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharma and Biomedics, online erschienen am 04.11.2026. Verfasst von Roheena Zafar und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) is a leading global health threat, and conventional culture-based identification and susceptibility testing usually takes two to three days, during which patients with serious infection receive empirical therapy that may be inactive or needlessly broad. This narrative review examines rapid diagnostic methods for detecting AMR in clinical microbiology and their role in guiding antibiotic treatment. Literature published between 2000 and 2024 was searched in PubMed, Scopus and Google Scholar and supplemented with CLSI, EUCAST, WHO and IDSA guidance. Methods are grouped as phenotypic (rapid carbapenemase assays, short-incubation disk diffusion, automated growth-based platforms, single-cell imaging), proteomic (MALDI-TOF mass spectrometry) and genotypic (targeted and multiplex PCR, isothermal amplification, CRISPR-based assays, sequencing). Genotypic panels return organism identity and resistance markers within one to two hours of blood culture positivity, whereas rapid phenotypic platforms provide susceptibility results in roughly 4 to 8 hours. Trials and meta-analyses show that these tests shorten time to effective therapy and, when paired with antimicrobial stewardship, are associated with lower mortality, whereas testing without stewardship action yields little benefit. Important limitations include detection of known targets only, genotype-phenotype discordance, mixed-culture errors, cost and uneven access in low- and middle-income countries. For settings such as Pakistan, a stepwise strategy is proposed, beginning with low-cost phenotypic tools and strengthening quality systems before adopting mass spectrometry or molecular panels. Rapid diagnostics should complement, not replace, conventional susceptibility testing and should be selected according to local epidemiology and integrated into stewardship workflows.

Zitieren

APA

Zafar, R., Khan, T., Khan, H. Y., Naveed, Y., & Musa, B. (2026). Rapid Diagnostic Methods for Detecting Antimicrobial Resistance in Clinical Microbiology and Their Role in Guiding Antibiotic Treatment: A Narrative Review. Journal of Pharma and Biomedics, 4(4), 545-552. https://doi.org/10.56810/jpbm.004.04.0318

Vancouver

Zafar R, Khan T, Khan HY, Naveed Y, Musa B. Rapid Diagnostic Methods for Detecting Antimicrobial Resistance in Clinical Microbiology and Their Role in Guiding Antibiotic Treatment: A Narrative Review. Journal of Pharma and Biomedics. 2026;4(4):545-552. doi:10.56810/jpbm.004.04.0318

BibTeX
@article{Zafar2026,
  author = {Zafar, Roheena and Khan, Taimoor and Khan, Hafiz Yaseen and Naveed, Yaseen and Musa, Bilal},
  title = {Rapid Diagnostic Methods for Detecting Antimicrobial Resistance in Clinical Microbiology and Their Role in Guiding Antibiotic Treatment: A Narrative Review},
  journal = {Journal of Pharma and Biomedics},
  year = {2026},
  volume = {4},
  number = {4},
  pages = {545--552},
  doi = {10.56810/jpbm.004.04.0318}
}
Kostenlos starten →